Invasive esophageal Aspergillosis associated with acute myelogenous leukemia: Successful therapy with combination caspofungin and liposomal amphotericin B

Pediatric Hematology and Oncology

Volumn 24, Issue 1, 2007, Pages 63-68

  Alioglu, Bulent ^a   Avci, Zekai ^a   Canan, Oguz ^a   Ozcay, Figen ^a   Demirhan, Beyhan ^a   Ozbek, Namik ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Acute myelogenous leukemia; Aspergillus; Caspofungin; Liposomal amphotericin B

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CYTARABINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; ITRACONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BACKACHE; CASE REPORT; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DYSPHAGIA; ENDOSCOPIC BIOPSY; FEVER; HEARTBURN; HUMAN; INVASIVE ESOPHAGEAL ASPERGILLOSIS; LUNG; MALE; MORTALITY; MYCOSIS; NAUSEA; NEUTROPENIA; NONHUMAN; PANCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPERGILLOSIS; ESOPHAGEAL DISEASES; HUMANS; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MALE; PEPTIDES, CYCLIC;

EID: 33845249251     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010601001412     Document Type: Article

References (13)

1. Rosen GP, Nielsen K, Glenn S, Abelson J, Deville J, Moore TB. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol. 2005;27:135-140.
2. Martino R, Subira M. Invasive fungal infections in hematology: new trends. Ann Hematol. 2002;81:233-243.
3. Muller FM, Trusen A, Weig M. Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children. Eur J Pediatr 2002;161:563-574.
4. Alioglu B, Teksam M, Azak E, Ozbek N. Flashes in clinical hematology - case 24. Haema 2003;6:411-412.
5. Bergman S, Geisinger KR. Esophageal aspergillosis in cytologic brushings: report of two cases associated with acute myelogenous leukemia. Diagn Cytopathol. 2004;30:347-349.
6. Geisinger KR. Endoscopic biopsies and cytologic brushings of the esophagus are diagnostically complementary. Am J Clin Pathol. 1995;103:295-299.
7. Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Inf Dis. 2006;43:S15-527.
8. Maschmeyer G, Ruhnke M. Update on antifungal treatment of invasive Candida and Aspergillus infections. Mycoses. 2004; 47:263-276.
9. Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 2004;64:1997-2020.
10. Walsh TJ, Goodman JL, Pappas P, et al. Safety, tolerance, and pharmacokinetics of high-dose liposomal Amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother. 2001;45:3487-3496.
11. Candoni A, Mestroni R, Damiani D, et al. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. Eur J Haematol. 2005;75:227-233.
12. Cesaro S, Toffolutti T, Messina C, et al. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Eur J Haematol. 2004;73:50-55.
13. Aliff TB, Maslak PG, Jurcic JG, Heaney ML, Cathcart KN, Sepkowitz KA, Weiss MA. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer 2003;97:1025-1032.